Monday, September 23, 2013

'Making Land-based Aquaculture more Sustainable'

Quoting from The Fish Site today:

"Earlier this month, an International symposium brought together people from 15 countries to discuss how to improve land-based aquaculture, including its performance, sustainability, and cost of raising salmon and other fish...

...'For the first time this industry is seeing a technology that is scalable and gets a return on investment,' said Norman McCowan, President, Bell Aquaculture. The Freshwater Institute designed a closed-containment system for Bell to raise its signature perch on land that conserves water, reduces fertilizer use and provides chemical- and pesticide-free healthy fish for human consumption."

Link to The Fish Site

Video First Look: 2013 Rocky Mountain Life Science Investor and Partnering Conference

Clovis Oncology CEO Pat Mahaffy: 'We're In A Good Cycle Now'

Array BioPharma CEO Ron Squarer: 'Advantages of Colorado'

Jeff Calcagno, MD, with J&J Development Corp: 'I'll Tell You What We're Looking For'

A video selection of the thirty regional presenting companies:

Ventria Bioscience, Fort Collins, CO:
AmideBio, Louisville, CO:
Renaptys Vaccines, Aurora, CO:
Sinopsys Surgical, Boulder, CO:
FitBionic, Boulder, CO:
Xenograft, Missoula, MT:
Wasatch Microfluidics, Salt Lake City, UT:
Neuro Assessment Systems, Littleton, CO:
NASSEO, Peoria, AZ:

CBSA Pres/CEO April Giles - Thanks to the RMLIPC Regional Sponsoring Organizations

Fitzsimons Redevelopment Authority Pres/CEO Steve VanNurden Welcoming Remarks RMLIPC Opening Reception

Link to the conference webpage

Friday, September 20, 2013

CBSA partners with two of the State’s Economic Development Entities to Promote Colorado’s Strengths at AdvaMed 2013  

Representatives from the Colorado BioScience Association (CBSA), the Colorado Springs Regional Business Alliance and the Metro Denver Economic Development Corporation will showcase Colorado’s medical device and diagnostic sectors during 'AdvaMed 2013: The MedTech Conference,' September 23-25, in Washington, D.C. The announcement is made by April Giles, CBSA President and CEO, who says more than 1,000 industry experts and thought leaders will participate in over 40 educational panels and executive workshops during the event, including the following CBSA members:

Metro Denver Economic Development Corporation,
Colorado Springs Regional Business Alliance,
Baxter International Inc.,  
Cardinal Health,
CEA Medical Manufacturing,
C. R. Bard, Inc.,  
Johnson & Johnson,               
MBio Diagnostics, Inc.,
Silicon Valley Bank,               
Society of Physician Entrepreneurs (SoPE),
St. Renatus, LLC,       
Terumo BCT,             
The Conafay Group,          

“This will be the CBSA’s seventh year participating in the AdvaMed Conference and each year the potential connections and opportunity to showcase Colorado’s medical device and diagnostic industries becomes even more abundant,” said Giles. “Over the last five years Colorado technology and companies have received over $600 million in investment capital and the life science community is garnering national attraction for its continued success. We also continue to be ranked as the 6th largest medical device cluster in the nation with over 340 medical device, diagnostic and instruments companies. Colorado is positioned as a leader in this sector and this conference provides us an opportunity to promote the state.”

Link to the Business Wire Release

Link to the PitchEngine Social Media Release

Coverage: CBSA's Rocky Mountain Life Science Investor and Partnering Conference 2013

Quoting: "The vetted companies came from Colorado, Arizona, Utah, New Mexico and Montana with hopes of attracting investment to move their products – focused on cancer, multiple sclerosis, diabetes, Lyme disease, wound repair and a host of other bioscience challenges – toward commercialization and profitability.

The day-long conference kicked off with a breakfast keynote “fireside chat” featuring Kyle Lefkoff, founder of Boulder Ventures, moderating a discussion with the leaders of two of Colorado’s premier publicly traded life science companies – Patrick Mahaffy, CEO and co-founder of Clovis Oncology and Ron Squarer, CEO of Array BioPharma, who shared their views on the state of Colorado’s bioscience industry"

Link to the posting

Quoting: "Executives of two Boulder-based biopharmaceutical companies said Thursday that early-stage pharma business in Colorado is hampered by the lack of a stable core that can be built around. Speaking at the Rocky Mountain Life Science Investor and Partnering Conference at the Ritz-Carlton, the two said they do their best in an environment that can be at once frustrating and invigorating."

Link to the posting

Monday, September 16, 2013

30+ Life Science Investors & Strategic Partners Convene In Denver This Week For 2013 Rocky Mountain Life Science Investor & Partnering Conference

More than thirty of the industry’s leading investors and strategic partners will attend presentations by the region’s most innovative life science companies at the 2013 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC), September 18-19 at the The Ritz-Carlton, Denver.

The announcement is made by April Giles, President & CEO of the Colorado BioScience Association (CBSA) who says, “Leading biotech, medical device, diagnostic and pharmaceutical investors from across the country will be coming to Denver to connect and invest in the regions emerging life science companies. Each company will make a 10-minute presentation to an audience of their peers, investors and partners, followed by a 5-minute period of questions—this type of high-pressure pitching is typical in vying for highly coveted VC funding.”

“The RMLIPC really showcases the best companies from the region and provides investors an opportunity to evaluate these fresh investment opportunities and meet one-on-one with their founders and executive team,” said Giles. “It’s important to note, the Rocky Mountain region is a key player in the life science industry. There has been over $1 billion in investment in the region over the past five years.”

The following investors and strategic partners will be attending RMLIPC 2013: 

Amgen Ventures, Thousand Oaks, CA -
Aphelion Capital, Mill Valley, CA -  
Bay City Capital, San Francisco, CA -
BioGenerator, St. Louis, MO -  
Boulder Ventures, Boulder, CO -  
Charter Life Sciences, Santa Clara, CA -  
Covidien, Mansfield, MA -
Epic Ventures, Albuquerque, NM -
GE Healthcare Financial Services, Chicago, IL -
Goodworks Ventures, MT -
High Country Venture, Boulder, CO -  
Johnson & Johnson Development Corporation, New Brunswick, NJ -  
KMG Capital Partners, Denver CO
Level 5 Partners, Fort Collins, CO -  
Lightstone Ventures, Boulder, CO -  
Mercury Fund, Houston, TX -  
Mile High Fund, Denver, CO -  
Morgenthaler Ventures, Menlo Park, CA  -  
New Enterprise Associates, Menlo Park, CA -  
Novartis Venture Funds, Cambridge, MA -  
Red Script Ventures, New Brunswick, NJ -
Remeditex, Dallas, TX -  
Salt Lake Life Science Angels, Salt Lake City, UT - 
Sanderling Ventures, San Mateo, CA -  
Signal Peak Ventures, Salt Lake City, UT -     
Silicon Valley Bank, Broomfield, CO -
Split Rock Partners, Menlo Park, CA -  
SR One, Corporate VC Arm of GlaxoSmithKline, San Francisco, CA -
Volcano Capital, New York, NY -  
Wayne Brown Institute, Salt Lake City, UT -  

Wexford Capital LP, Greenwich, CT -  

About the Rocky Mountain Life Science Investor & Partnering Conference 

The 2013 Rocky Mountain Life Science Investor & Partnering Conference – spearheaded by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah — will open with a reception at the Colorado Governor’s Mansion September 18th and follow with a full day of company pitch presentations September 19th. The keynote breakfast will include Kyle Lefkoff, founder and General Partner of Boulder Ventures, leading a conversation with the CEOs of Colorado's two premier publicly-traded pharmaceutical companies-Patrick Mahaffy, Founder and CEO of Clovis Oncology and Ron Squarer, CEO of Array BioPharma. The keynote lunch titled “New Approaches to Healthcare Innovation” will be a presentation from Jeff Calcagno, M.D., Venture Investments with Johnson & Johnson Development Corporation. For more information and registration details, visit

On Twitter, please use the hashtag #RockyMtnBioInvest for your tweets.

Friday, September 13, 2013

Lakeside Views: 'Aquaculture industry continues to grow in the Midwest'

Quoting from the 9/12 posting:

"IISG staff will have the opportunity to see aquaculture in action next week while touring the Bell Aquaculture facility in Albany, IN. IISG's Kwamena Quagrainie has been studying and providing expert advice to aquaculture operations in the Midwest and worldwide for many years, and will be giving the staff more information on how the facility provides millions of pounds of sustainably grown fish to the market each year."

Link to the posting

Link to the Illinois-Indiana Sea Grant Aquaculture webpage

Wednesday, September 11, 2013

CompanyWeek: 'Attracting Capital Is Key for Start-Up Bioscience Companies'

Quoting from today's CompanyWeek, column by Colorado BioScience Association President/CEO April Giles:

"Every other year the Colorado Bioscience Association, in collaboration with Johnson & Johnson Development Corporation, brings investors and funding partners to our home turf with the Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC). We work hard to vet 30 fantastic presenting companies and intrigue 50 out of state investors – angel, VC, venture funds and business development arms to strategic partners – to Colorado to look at an undermined, yet highly valuable bioscience community."

Link to CompanyWeek

Monday, September 9, 2013

Medical Device Daily: "A decade of growth in metro Denver’s medical device sector"

Quoting from today's profile in Medical Device Daily by Jeffrey Berg:

"The medical device sector in Metro Denver region has experienced dramatic growth over the past decade, including 16% growth during the years of recession, 2001-2010. This growth followed a report issued in March 2003 by the Governor’s office entitled 'Colorado’s Place in the Sun: A Bioscience Future, An Action plan to Grow Colorado’s Bioscience Cluster.' Metro Denver currently ranks as the sixth largest cluster of medical device companies in the U.S. Over the past five years, the region has seen more growth in device companies than biotech or pharmaceuticals."

Link to CBSA News

Wednesday, September 4, 2013

Leading CEOs Keynote 2013 Rocky Mountain Life Science Investor and Partnering Conference in Denver

The 2013 Rocky Mountain Life Science Investor and Partnering Conference keynote breakfast will include Kyle Lefkoff, founder and General Partner of Boulder Ventures, leading a conversation with the CEOs of Colorado's two premier publicly-traded pharmaceutical companies – Patrick Mahaffy, Founder and CEO of Clovis Oncology and Ron Squarer, CEO of Array BioPharma. The announcement is made by April Giles, President and CEO of the Colorado BioScience Association (CBSA) who says the regional conference will also feature a keynote luncheon presentation by Jeff Calcagno, M.D., Principal, Venture Investments, Johnson and Johnson Development Corporation.

Lefkoff, one of the region’s leading venture capitalists and a member of the conference steering committee since 2009, says: “Clovis Oncology and Array BioPharma have been incredibly successful reaching both funding and developmental milestones. This is a great opportunity to hear first-hand from their leadership how they have achieved this success and what they look forward to in the future.”

Link to the Business Wire release

Link to the PitchEngine Social Media Release

Tuesday, September 3, 2013

AgriNews: 'Hoosier is honored for commitment to aquaculture'

Quoting from today's posting by Ashley Bechman:

"The only thing fishy about this year’s Indiana Agrivision Award recipient is his passion for aquaculture and growing it into a billion-dollar industry.

Lt. Gov. Sue Ellspermann presented Norman McCowan, president and chief executive officer of Bell Aquaculture in Redkey, with the Indiana Agrivision Award, which is given to a Hoosier involved in agriculture for their demonstration, vision, innovation and leadership in the industry...

...McCowan, who was nominated for the award by his peers in the agriculture community, including the U.S. Department of Agriculture and the Indiana Soybean Alliance, noted that his love for fish stems from his childhood days when he would catch minnows and figure out the water and the temperature in which the fish thrived. Today, that boyhood hobby has turned into something much bigger as McCowan now oversees all of the work that goes into producing Bell Aquaculture’s farm-raised yellow perch."

Link to AgriNews